INOVIO PHARMACEUTICALS, INC. Capital Expenditures Incurred but Not yet Paid
INOVIO PHARMACEUTICALS, INC. (INO) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-06-30 was $66.69K.
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$442.98K.
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $442.98K.
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $108.18K, a 47.18% decline from fiscal 2021.
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $204.81K, a 49.82% increase from fiscal 2020.
- INOVIO PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2020 was $136.71K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | ||||
| 2025-06-30 | $66.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $66.69K 10-Q · filed 2026-08-12 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | ||||
| 2024-06-30 | -$442.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-08-12 | $0.00 derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $442.98K 10-Q · filed 2025-05-13 | $442.98K derived: sum of 2 quarters · filed 2025-05-13 | $442.98K derived: sum of 3 quarters · filed 2025-05-13 | $442.98K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 10-K · filed 2024-03-06 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | -$154.01K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | -$154.01K derived: sum of 3 quarters · filed 2024-05-13 | $40.54K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | -$154.01K derived: sum of 2 quarters · filed 2024-05-13 | $40.54K derived: sum of 3 quarters · filed 2024-05-13 | -$222.60K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | -$154.01K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $40.54K derived: sum of 2 quarters · filed 2024-03-06 | -$222.60K derived: sum of 3 quarters · filed 2024-03-06 | $108.18K 10-K · filed 2024-03-06 | |
| 2022-09-30 | $194.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$68.59K derived: sum of 2 quarters · filed 2023-11-09 | $262.19K 10-Q · filed 2023-11-09 | $437.93K derived: sum of 4 quarters · filed 2024-03-06 | |
| 2022-06-30 | -$263.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $67.64K 10-Q · filed 2023-08-09 | $243.38K derived: sum of 3 quarters · filed 2024-03-06 | $272.46K derived: sum of 4 quarters · filed 2024-03-06 | |
| 2022-03-31 | $330.78K 10-Q · filed 2023-05-10 | $506.51K derived: sum of 2 quarters · filed 2024-03-06 | $535.59K derived: sum of 3 quarters · filed 2024-03-06 | $500.22K derived: sum of 4 quarters · filed 2024-03-06 | |
| 2021-12-31 | $175.74K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $204.81K derived: sum of 2 quarters · filed 2024-03-06 | $169.44K derived: sum of 3 quarters · filed 2024-03-06 | $204.81K 10-K · filed 2024-03-06 | |
| 2021-09-30 | $29.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$6.29K derived: sum of 2 quarters · filed 2022-11-08 | $29.08K 10-Q · filed 2022-11-08 | -$32.97K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$35.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | -$62.05K derived: sum of 3 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $35.37K 10-Q · filed 2022-05-10 | -$26.68K derived: sum of 2 quarters · filed 2023-03-01 | |||
| 2020-12-31 | -$62.05K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $136.71K 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $198.76K 10-Q · filed 2021-11-09 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | ||||
| 2018-12-31 | $559.65K 10-K · filed 2021-03-01 | $694.47K 10-K · filed 2019-03-12 | |||
| 2017-12-31 | $1.25M 10-K · filed 2020-03-12 | $851.20K 10-K · filed 2018-03-14 | |||
| 2017-03-31 | $511.05K 10-Q · filed 2017-05-10 | $506.00K derived: sum of 2 quarters · filed 2019-03-12 | $786.11K derived: sum of 3 quarters · filed 2019-03-12 | $17.12K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2016-12-31 | -$5.06K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $275.06K derived: sum of 2 quarters · filed 2019-03-12 | -$493.93K derived: sum of 3 quarters · filed 2019-03-12 | $164.92K 10-K · filed 2019-03-12 | |
| 2016-09-30 | $280.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$488.87K derived: sum of 2 quarters · filed 2016-11-09 | $169.98K 10-Q · filed 2016-11-09 | -$80.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | -$768.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$110.14K 10-Q · filed 2016-08-08 | -$360.11K derived: sum of 3 quarters · filed 2018-03-14 | -$75.10K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | $658.85K 10-Q · filed 2017-05-10 | $408.88K derived: sum of 2 quarters · filed 2018-03-14 | $693.89K derived: sum of 3 quarters · filed 2018-03-14 | $835.37K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | -$249.97K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $35.04K derived: sum of 2 quarters · filed 2018-03-14 | $176.52K derived: sum of 3 quarters · filed 2018-03-14 | $225.15K 10-K · filed 2018-03-14 | |
| 2015-09-30 | $285.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $426.49K derived: sum of 2 quarters · filed 2016-11-09 | $475.12K 10-Q · filed 2016-11-09 | $398.43K derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | $141.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $190.11K 10-Q · filed 2016-08-08 | $113.41K derived: sum of 3 quarters · filed 2017-03-15 | $113.41K derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-03-31 | $48.63K 10-Q · filed 2016-05-09 | -$28.07K derived: sum of 2 quarters · filed 2017-03-15 | -$28.07K derived: sum of 3 quarters · filed 2017-03-15 | ||
| 2014-12-31 | -$76.70K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$76.70K derived: sum of 2 quarters · filed 2017-03-15 | $12.84K 10-K · filed 2017-03-15 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $89.54K 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | $89.54K 10-Q · filed 2015-08-10 | ||||
| 2013-12-31 | $139.17K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |